Cita APA

Ruiz de Porras, V., Bernat Peguera, A., Alcon, C., Laguia, F., Fernández Saorin, M., Jiménez, N., . . . Font, A. (2024). Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.

Citación estilo Chicago

Ruiz de Porras, Vicenç, et al. Dual Inhibition of MEK and PI3Kβ/δ-a Potential Therapeutic Strategy in PTEN-wild-type Docetaxel-resistant Metastatic Prostate Cancer. 2024.

Cita MLA

Ruiz de Porras, Vicenç, et al. Dual Inhibition of MEK and PI3Kβ/δ-a Potential Therapeutic Strategy in PTEN-wild-type Docetaxel-resistant Metastatic Prostate Cancer. 2024.